You are here: Industry Insights > drug

News List

FDA takes first action under new international collaboration with Australia and Canada worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
Off-Label Ordering of Systemic Drugs Up for Children drugs
September 18, 2019
The rate of off-label ordering of systemic drugs has increased for children, according to a study published online Sept. 16 in Pediatrics.
Gene-targeted cancer drugs, slow release overcome resistance worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...
FDA grants Orphan Drug Designation to sotatercept europeanpharmaceuticalreview
September 16, 2019
Orphan Drug Designation has been given to sotatercept for the treatment of patients with pulmonary arterial hypertension.
FDA emphasises need for adverse event reporting of compounded drugs europeanpharmaceuticalreview
September 16, 2019
The FDA says that even though it recognises the importance of compounded drugs, they also pose a risk to patient safety.
New drug may protect against memory loss in Alzheimer's disease worldpharmanews
September 10, 2019
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss...
Federal judge enters consent decree against drug distributors europeanpharmaceuticalreview
September 10, 2019
Two Tennessee companies have been prevented from distributing drugs after a complaint they were supplying unapproved medications.
Cyxone Explores Orphan Drug Designation for Rabeximod americanpharmaceuticalreview
September 09, 2019
Cyxone announced the company's board of directors has decided to explore the possibilities of an orphan drug designation (ODD) of the drug candidate Rabeximod.
Underused Drug Combo May Up Survival in Lung Transplant drugs
September 06, 2019
A little used immunosuppression regimen may substantially improve survival following lung transplant, according to a study published online in JAMA Network Open.
Drug delivery improved through mesoporous materials europeanpharmaceuticalreview
September 06, 2019
A new study on DOX as a model drug has potential applications in the drug delivery field for better control drug release.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page